Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04014322
Other study ID # 1089
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 12, 2020
Est. completion date December 2024

Study information

Verified date September 2023
Source Fordham University
Contact Haruka Minami, Ph.D.
Phone (718) 817-3885
Email hminami@fordham.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to establish the feasibility and acceptability of a project designed to investigate the impact of electronic cigarette use on combustible cigarette smoking and smoking-related factors among smokers with psychiatric disorders, a high-risk population, who are not yet ready to quit smoking. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.


Description:

In recent years, the prevalence of e-cigarette use has rapidly increased, especially among those with psychiatric conditions, and the risks and potential benefits of e-cigarette use have been the topic of much debate. More research is needed to understand the impact of e-cigarette use on smoking behavior and smoking-related cognitions among individuals with psychiatric conditions. This study will investigate the effects of e-cigarette use on cigarette smoking and motivation/readiness to quit among smokers with psychiatric disorders who are not yet ready to quit smoking. A total of 50 adult daily cigarette smokers who are receiving outpatient psychiatric treatment and not yet ready to quit smoking will be recruited. All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8 weeks. E-cigarettes will be provided to participants at no cost. Participants will also be asked to complete 5 (remote and in-person) assessment sessions (i.e., baseline, 2-week, 4-week, 8-week and 12-week follow-ups).


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - 21 years of age or older - English-speaking, - current daily smokers (i.e., at least 5 cigarettes/day) - have been daily smokers at least for 6 months - attended a minimum of 2 treatment visits in the past 12 months at Montefiore Behavioral Health Center - have at least one psychiatric disorder (other than substance use disorders), - willing to try switching to use e-cigarettes (provided by the research team) exclusively for a total of 8 weeks, - those who are not yet ready to quit smoking, - for women of childbearing age, willingness to use contraception during the study. Exclusion Criteria: - acute psychiatric symptomatology which precludes study participation including current active suicidal ideation - current diagnosis of dementia or cognitive impairment sufficient to impair provision of informed consent or study participation - patient's inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures as contained in the statement of informed consent, after no more than two explanations - current clinical diagnosis of intellectual development disorder - current regular use of other tobacco products or combustible marijuana - current (non-nicotine) substance use disorder and current substance use (in the past month) - current effort to quit smoking or current use of pharmacotherapy (in the past month) to quit smoking, - pregnant, breastfeeding, or planning to become pregnant within 6 months, current unstable cardiovascular disease, - current unstable pulmonary disease (i.e., an ER visit or hospitalization due to pulmonary issues in the past 6 month or current use of oxygen therapy), - patient does not have a stable home address where the research team could reliably reach patient - household members are currently participating or have participated in this research study

Study Design


Intervention

Other:
E-cigarette
All participants will be provided with 8 weeks of e-cigarettes at no cost based on self-report of regular cigarette use. All participants will receive a total of 8-10 remote counseling sessions (via phone or video conference) and during which they will discuss ways to switch from smoking cigarettes to exclusively using e-cigarettes, barriers and strategies to overcome them. (All participants will receive sessions at baseline, 2 days, 7 days, 2 weeks, 3 weeks, and 4 weeks, 6 weeks , and 8 weeks after the baseline assessment. Two additional sessions at 5 weeks and 7 weeks (after the baseline assessment) will be provided to those who are still smoking combustible cigarettes at 4-week assessment.)

Locations

Country Name City State
United States Montefiore Behavioral Health Center Bronx New York

Sponsors (3)

Lead Sponsor Collaborator
Fordham University Dartmouth College, Montefiore Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the number of combustible cigarettes smoked per day The average number of cigarettes smoked per day Baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks
Primary Changes in Carbon Monoxide Level Changes in Carbon monoxide level measured with a breath carbon monoxide monitor Baseline,2 weeks, 4 weeks, 8 weeks, 12 weeks
Primary Changes in Nicotine Dependence Fagerstrom Test of Cigarette Dependence Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Primary Changes in the use of e-cigarettes Changes in the use of e-cigarettes Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Primary Rates of those who completely switched to e-cigarettes Rates of those who completely switched to e-cigarettes Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Secondary Changes in Motivation/Readiness to Quit Smoking Thoughts about Abstinence Scale & Contemplation Ladder Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Secondary Changes in Withdrawal Symptoms Minnesota Nicotine Withdrawal Scale Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Recruiting NCT04038255 - Mindfulness Based Smoking Cessation Among Cancer Survivors Phase 4
Completed NCT04123041 - Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems N/A
Completed NCT02735382 - EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study N/A
Completed NCT02139930 - Project 2: Strategies for Reducing Nicotine Content in Cigarettes N/A
Completed NCT04107779 - Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS N/A
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Completed NCT04200157 - Testing the Decoy Effect to Increase Tobacco Treatment Uptake
Enrolling by invitation NCT06042361 - Enhancing Equity in Smoke-free Housing N/A
Completed NCT02841683 - Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention " Tabac Info Service " N/A
Completed NCT03151421 - Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home N/A
Completed NCT04104152 - CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting N/A
Recruiting NCT05306158 - Dual Use Approach Bias Training for Nicotine Addiction N/A
Completed NCT04094363 - CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems N/A
Completed NCT04143256 - Evaluating Selected Constituents in the Exhaled Breath Samples N/A
Completed NCT03553992 - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers N/A
Completed NCT05102786 - CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
Terminated NCT04396847 - Laboratory Screening of Lorcaserin for Alcohol Use Disorder Phase 2
Completed NCT03694327 - Innovative Digital Therapeutic for Smoking Cessation N/A
Completed NCT05030194 - Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study] N/A